Treatment of systolic hypertension in the elderly should be based on nonpharmacological measures and medical therapy if the systolic hypertension cannot be controlled by conservative therapy alone.

RADNOR, Pa. - Mineralys Therapeutics , Inc. (NASDAQ:MLYS), a biopharmaceutical company specializing in the development of treatments for cardiovascular and kidney diseases, has announced the ...

Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild ...

The stages of hypertension include elevated, stage 1, stage 2 and hypertensive crisis. These readings are above 120/80 mm Hg.

The company was testing its therapy, cibotercept, in patients with pulmonary arterial hypertension (PAH ... was aiming to compete with Merck's PAH treatment (MRK.N), opens new tab Winrevair ...

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

The human body contains over 70,000 miles of blood vessels, lined by a single layer of endothelial cells. This inner lining, ...

Beyond blood pressure, Roblyer’s team is exploring how light can help track cancer treatment. In collaboration with Dr. Naomi ...

What are the symptoms of anemia and hypertension? These are the potential ... condition so you can receive a proper diagnosis and treatment. Healthline has strict sourcing guidelines and relies ...

Effective treatment of childhood obesity significantly lowers long-term health risks, including type 2 diabetes and ...